Jean-Benoit Monfort
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jean-Benoit Monfort has a total of 220 co-authors. Here are the top co-authors by number of shared publications:
A. Barbaud
Médecine, Sorbonne université, 75013 Paris 06, France; Service de dermatologie, UF de dermatologie vasculaire, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
8 shared publicationsP. Senet
Médecine, Sorbonne université, 75013 Paris 06, France; Service de dermatologie, UF de dermatologie vasculaire, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
8 shared publicationsPatricia Senet
Service de Dermatologie, Hôpital Tenon Sorbonne Université Paris France
7 shared publicationsP. Moguelet
AP‐HP, Service de Pathologie Hôpital Tenon Sorbonne Université Paris 75020 France
6 shared publicationsC. Francès
4 shared publicationsC. Cassius
3 shared publications
Latest Publications
- 18 July 2026
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 153 (3) , 103518
Management of erythromelalgia: A retrospective multicenter study
- 18 July 2026
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 153 (3) , 103518
Management of erythromelalgia: A retrospective multicenter study
- 23 June 2026
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 152, 107021
Chronic hyperkeratotic and pustular cutaneous lesions of the hand
- 23 June 2026
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 152, 107021
Chronic hyperkeratotic and pustular cutaneous lesions of the hand
- 16 December 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6) , 946-962
Recommendations for the diagnostic work‐up of cutaneous small vessel vasculitis – Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force
Background: Small vessel vasculitides (SVV) comprise a heterogeneous group of cutaneous SVV (CSVV) that can be skin‐limited or systemic. Given their diverse forms and symptoms and the lack of a standardized diagnostic approach, it is crucial to establish clear and consensus‐driven recommendations for diagnosis. Objectives: To standardize diagnosis for the detection of the type, extent, potential causes or underlying conditions of CSVV. Methods: International experts comprised the panel. The Delphi panel data was collected through two rounds of questionnaires. Agreement was measured using an 11‐point Likert scale (0 = strongly disagree, 10 = strongly agree). A 7‐vote minimum was required for agreement on each statement. Delphi panel statements scoring 3–7 were discussed during the meeting. Results: 20 experts participated in the first round of the Delphi panel, while 17 experts took part in the second. They agreed that the diagnosis of CSVV relies on a combination of clinical manifestations, laboratory findings and histopathology. Palpable purpura on the lower extremities is recognized as the most reliable hallmark for most SVV and a sign of immune complex vasculitis. When the latter is suspected, a skin biopsy for direct immunofluorescence (DIF) should be obtained from an early, partially blanchable macule because the type of perivascular immunoglobulin is important for further diagnosis. The proper selection of biopsy sites for routine HE biopsy depends on the morphology of lesions. A comprehensive medical history and selected laboratory testing should be conducted to investigate organ involvement, potential causes and associated conditions. The extent of diagnostic procedures should be based on the severity, duration, systemic symptoms and recurrence of SVV. Conclusions: Experts reached a strong consensus on the management of CSVV patients, culminating in the first International Consensus Statement for adult CSVV. This statement proposes a practical management algorithm and underscores the importance of collaboration in rare diseases management.
- 16 December 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6) , 946-962
Recommendations for the diagnostic work‐up of cutaneous small vessel vasculitis – Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force
Background: Small vessel vasculitides (SVV) comprise a heterogeneous group of cutaneous SVV (CSVV) that can be skin‐limited or systemic. Given their diverse forms and symptoms and the lack of a standardized diagnostic approach, it is crucial to establish clear and consensus‐driven recommendations for diagnosis. Objectives: To standardize diagnosis for the detection of the type, extent, potential causes or underlying conditions of CSVV. Methods: International experts comprised the panel. The Delphi panel data was collected through two rounds of questionnaires. Agreement was measured using an 11‐point Likert scale (0 = strongly disagree, 10 = strongly agree). A 7‐vote minimum was required for agreement on each statement. Delphi panel statements scoring 3–7 were discussed during the meeting. Results: 20 experts participated in the first round of the Delphi panel, while 17 experts took part in the second. They agreed that the diagnosis of CSVV relies on a combination of clinical manifestations, laboratory findings and histopathology. Palpable purpura on the lower extremities is recognized as the most reliable hallmark for most SVV and a sign of immune complex vasculitis. When the latter is suspected, a skin biopsy for direct immunofluorescence (DIF) should be obtained from an early, partially blanchable macule because the type of perivascular immunoglobulin is important for further diagnosis. The proper selection of biopsy sites for routine HE biopsy depends on the morphology of lesions. A comprehensive medical history and selected laboratory testing should be conducted to investigate organ involvement, potential causes and associated conditions. The extent of diagnostic procedures should be based on the severity, duration, systemic symptoms and recurrence of SVV. Conclusions: Experts reached a strong consensus on the management of CSVV patients, culminating in the first International Consensus Statement for adult CSVV. This statement proposes a practical management algorithm and underscores the importance of collaboration in rare diseases management.
- 17 November 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6)
Leg ulcers associated with tyrosine kinase inhibitors of vascular endothelial growth factor receptors
- 17 November 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6)
Leg ulcers associated with tyrosine kinase inhibitors of vascular endothelial growth factor receptors
- 10 July 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (2)
Withdrawal of biologic agents before pregnancy is associated with psoriasis flare
- 10 July 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (2)
Withdrawal of biologic agents before pregnancy is associated with psoriasis flare
- 15 April 2025
- Published by Elsevier in Vascular Diseases
- Vol. 50 (1) , 32-33
Prise en charge des érythermalgies : étude rétrospective multicentrique
- 15 April 2025
- Published by Elsevier in Vascular Diseases
- Vol. 50 (1) , 32-33
Prise en charge des érythermalgies : étude rétrospective multicentrique
- 15 April 2025
- Published by Elsevier in Vascular Diseases
- Vol. 50 (1) , 26-27
Dermoscopie et capillaroscopie
- 15 April 2025
- Published by Elsevier in Vascular Diseases
- Vol. 50 (1) , 26-27
Dermoscopie et capillaroscopie
- 22 January 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (10) , 1982-1987
Nailfold dermoscopy predicts the absence of a capillaroscopy sclerodermic pattern: The multicentre, prospective VASCUL‐R trial
Background: Nailfold capillaroscopy is recommended to diagnose primary or secondary Raynaud's phenomenon (RP). Capillaroscopy is normal in primary RP, which is the most frequent. Screening for RP capillary anomalies with nailfold dermoscopy has been promising.Objective: To determine whether normal nailfold dermoscopy—based on the absence of five criteria that define a sclerodermic pattern—is able to predict normal capillaroscopy with good positive‐predictive value (PPV).Methods: Prospective, 2‐phase (monocentre and multicentre) study on patients at first consultation for RP undergoing nailfold video capillaroscopy (NVC) and nailfold dermoscopy by two different ‘blinded’ trained observers, respectively, a vascular specialist and a dermatologist, not familiar with capillaroscopy. The five criteria noted were as follows: disorganization, megacapillaries, low capillary density, avascular areas and haemorrhages.Results: Based on 105 patients, the dermoscopy PPV for a normal NVC was 100% (p = 0.015), with 37.9% sensitivity, when no criterion was observed. Excluding haemorrhages, the PPV remained 100% (p < 0.0001), with sensitivity rising to 73.7% and 100% specificity.Conclusions: Normal nailfold dermoscopy with the absence of four easy‐to‐observe criteria predicts normal NVC with an excellent PPV.
- 22 January 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (10) , 1982-1987
Nailfold dermoscopy predicts the absence of a capillaroscopy sclerodermic pattern: The multicentre, prospective VASCUL‐R trial
Background: Nailfold capillaroscopy is recommended to diagnose primary or secondary Raynaud's phenomenon (RP). Capillaroscopy is normal in primary RP, which is the most frequent. Screening for RP capillary anomalies with nailfold dermoscopy has been promising.Objective: To determine whether normal nailfold dermoscopy—based on the absence of five criteria that define a sclerodermic pattern—is able to predict normal capillaroscopy with good positive‐predictive value (PPV).Methods: Prospective, 2‐phase (monocentre and multicentre) study on patients at first consultation for RP undergoing nailfold video capillaroscopy (NVC) and nailfold dermoscopy by two different ‘blinded’ trained observers, respectively, a vascular specialist and a dermatologist, not familiar with capillaroscopy. The five criteria noted were as follows: disorganization, megacapillaries, low capillary density, avascular areas and haemorrhages.Results: Based on 105 patients, the dermoscopy PPV for a normal NVC was 100% (p = 0.015), with 37.9% sensitivity, when no criterion was observed. Excluding haemorrhages, the PPV remained 100% (p < 0.0001), with sensitivity rising to 73.7% and 100% specificity.Conclusions: Normal nailfold dermoscopy with the absence of four easy‐to‐observe criteria predicts normal NVC with an excellent PPV.
- 20 February 2023
- Published by Elsevier in JMV-Journal de Médecine Vasculaire
- Vol. 48, S30-S31
Étude BRASS : évaluation de l’efficacité de la toxine botulinique dans le phénomène Raynaud secondaire à la sclérodermie systémique
- 20 February 2023
- Published by Elsevier in JMV-Journal de Médecine Vasculaire
- Vol. 48, S30-S31
Étude BRASS : évaluation de l’efficacité de la toxine botulinique dans le phénomène Raynaud secondaire à la sclérodermie systémique